Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 473-690-8 | CAS number: 738602-93-2
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Jan 2004 - Mar 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- study initiated and performed before 2017.
- Species:
- guinea pig
- Strain:
- other: Himalayan spotted
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, CH-4414 Füllinsdorf, Switzerland
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: SPF stated
- Age at study initiation: 4-6 weeks
- Weight at study initiation: 370-401 g
- Housing: individually
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days
- Indication of any skin lesions: Only animals without any visible signs of illness were used for the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C):
- Humidity (%):
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light):
- IN-LIFE DATES: From: To: - Route:
- intradermal
- Vehicle:
- water
- Concentration / amount:
- 75 %
- Day(s)/duration:
- on day 1
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 0.3 mL
- Day(s)/duration:
- on day 8, 48 hours duration
- Adequacy of induction:
- highest technically applicable concentration used
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 25 %, 0.2 mL
- Day(s)/duration:
- day 22, 24 hours duration
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- intradermal pretest 1
epidermal pretest 2
control group 5
test group 10
positive control group 10 (study nr 849402) - Details on study design:
- RANGE FINDING TESTS: one intradermal pretest and one epidermal pretest performed
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: intradermal day 1 epidermal day 8
- Test groups: 1 concentration
- Control group: physiological saline
- Site: scapular area
- Frequency of applications: once for each route
- Duration: intradermal - epidermal 48 h
- Concentrations: intradermal 75 %, epidermal 100 %
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 22
- Exposure period: 24 h
- Test groups: one test group
- Control group: water
- Site: left and right flank
- Concentrations: 25 % test substance in vehicle
- Evaluation (hr after challenge):
OTHER: Freund's complete adjuvant used during intradermal injection as well - Challenge controls:
- purified water
- Positive control substance(s):
- yes
- Positive control results:
- All (at the 24-hour reading) and six (at the 48-hour reading) out of 10 test animals showed discrete/patchy erythema after the challenge treatment with Alpha-hexylcinnamaldehyde at 3 % (w/w) in PEG 300. NNo skin effect was observed in the control group.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0 % (water)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 0 % (water)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 % test item
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25 % test item
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 % test item
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 25 % test item
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- positive control
- Dose level:
- 3 %
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Clinical observations:
- No toxic symptoms were evident in the guinea pigs and no deaths occurred.
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 3%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- No toxic symptoms were evident in the guinea pigs and no deaths occurred.
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the findings in an adjuvant sensitization test in guinea pigs, MG-60 does not have to be classified and labelled as a skin sensitzier. One out of 10 test animals showed skin reactions after the challenge treatment with MG-60 at 25 % (w/w) in purified water.
- Executive summary:
In order to assess the cutaneous allergenic potential of MG-60, the Maximization-Test was performed in 15 (10 test and 5 control) female albino guinea pigs. A positive control study using 15 (10 positive control and 5 control) animals is reported as well.
The intradermal induction of sensitization in the test group was performed in the nuchal region with a 75 % dilution of the test item in purified water and in an emulsion of Freund's Complete Adjuvant (FCA)/physiological saline. The epidermal induction of sensitization was conducted for 48 hours under occlusion with the undiluted test item one week after the intradermal induction. The animals of the control group were intradermally induced with purified water under occlusion.
Two weeks after epidermal induction the control and test animals were challenged by epidermal application of the test item at 25 % in purified water and pruified ater alone under occlusive dressing. Cutaneous reactions were evaluated at 24 and 48 hours after removal of the dressing.
No toxic symptoms were evident in the guinea pigs of the control or test group.
No deaths occurred.
One our of 10 test animals showed skin reactions after the challenge treatment with MG-60 at 25 % (w/w) in purified water. No skin effect was observed in the control group.
The positive control substance proved to be a skin sensitiser (i.e. all test animals showed skin reactions after the challenge treatment).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available information is conclusive but not sufficient for classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
